CLSD - Clearside Biomedical Inc
IEX Last Trade
1.015
0.005 0.493%
Share volume: 73,302
Last Updated: Fri 30 Aug 2024 09:59:29 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$1.01
0.01
0.50%
Fundamental analysis
38%
Profitability
25%
Dept financing
48%
Liquidity
75%
Performance
40%
Performance
5 Days
-0.98%
1 Month
-12.93%
3 Months
-27.34%
6 Months
-28.37%
1 Year
9.72%
2 Year
-25.19%
Key data
Stock price
$1.02
DAY RANGE
N/A - N/A
52 WEEK RANGE
$0.65 - $2.12
52 WEEK CHANGE
$0.11
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/13/2024
Company detail
CEO: George Lasezkay
Region: US
Website: http://clearsidebio.com/
Employees: 39
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: http://clearsidebio.com/
Employees: 39
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
clearside biomedical, inc. is a pharmaceuticals company located in 1220 old alpharetta rd., suite 300, alpharetta, ga, united states.
Recent news